Sulfasalazine or Salazopyrin is indicated for the treatment of active Rheumatoid Arthritis and some other inflammatory arthropathies. It is normally used together with Non Steroidal Anti-inflammatory Drugs particularly in the early stages of treatment. Response to treatment cannot be expected before three months and may not occur until after six months of treatment.

CONTRA-INDICATIONS

DOSAGE

MONITORING

PRE TREATMENT SCREENING EACH MONITORING VISIT
  • Haemoglobin
  • Total white cell count
  • Neutrophil count
  • Platelet count
  • Biochemical Profile
  • Haemoglobin
  • Total white cell count
  • Neutrophil count
  • Platelet count
  • Liver function tests

ADVERSE EVENTS

LABORATORY EVENTS VALUES ACTION
Leucopaenia < 3.5 x 10 9 /l STOP + seek advice
Neutropaenia < 2.5 x 10 9 /l STOP + seek advice
Thrombocytopaenia < 150 x 10 9 /l STOP + seek advice
Macrocytosis > 100 Check B12 and folate
Sequential falls in WBC or neutrophils > 10% on 3 occasions STOP + seek advice
Sequential falls in Platelets > 10% on 3 occasions STOP unless falls are from high level e.g. 600, 500, 400 x 10 3 which are response to treatment
Elevation of liver enzymes (AST, ALT) > 3x normal
  • STOP drug
  • Repeat LFTs
  • Mild transaminitis is common and normally settles.

CLINICAL ADVERSE EVENTS MANAGEMENT
Rash Often non-specific erythematous, dry and itchy.
  • STOP drug if severe
  • Consider using 1% hydrocortisone and/or anti-histamines.
  • Consider other causes of rash.
  • If mild re-introduce drug when settled.
Mouth Ulcers/Stomatitis
  • STOP if severe.
  • Reduce dose if mild/moderate.
  • Consider carbenoxalone or Difflam mouth washes.
  • Consider other causes.
Fever/Flu like illness
  • STOP drug
  • Unusual hypersensitivity reaction
  • Do not re-introduce
Nausea
  • Reduce dose
  • Take with food, try anti-emetic.
  • STOP if unacceptable
Urine discolouration Reassure
Discolouration of soft contact lenses Warn patient

Source: Dr PR Crook, Consultant Rheumatologist.